The Washington Post
Business Context

AmerisourceBergen’s opioid tax disclosure

Updated Feb 12, 2021 at 12:13 PM EST

The drug distributor said in its annual SEC filing in November 2020 it expects to claim a $1.1 billion tax benefit after paying $6.6 billion into the nationwide opioid settlement. AmerisourceBergen said an additional $371.5 million tax benefit was possible but “uncertain.”


Click here to download if the document isn't visible or legible.

AmerisourceBergen's SEC filing where they disclose plans to take a tax deduction.